Howard G. Welgus
CIK 1801050 · Chief Medical Officer · last filed 2026-07-17
Howard G. Welgus is a Chief Medical Officer who has filed 111 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for ARQT, was dated Jul 17, 2026. Across all open-market trades the lifetime net is −$6.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.73M
1
111
-$6.48M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 66,830 | $25.92 | $1.73M | -$6.48M | 83 | 2026-07-17 |
Recent Filings
111 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-17 | ARQT | Mixed | −634 | -$94.8K | EDGAR |
| 2026-07-15 | ARQT | Notice (144) | −4,730 | -$127.3K | EDGAR |
| 2026-06-17 | ARQT | Mixed | −635 | -$83.8K | EDGAR |
| 2026-06-17 | ARQT | Notice (144) | −635 | -$16.3K | EDGAR |
| 2026-06-15 | ARQT | Notice (144) | −4,096 | -$100.0K | EDGAR |
| 2026-06-09 | ARQT | Grant (A) | +5,778 | $0 | EDGAR |
| 2026-05-05 | ARQT | Sell (S) | −7,144 | -$164.2K | EDGAR |
| 2026-05-01 | ARQT | Notice (144) | −7,144 | -$164.2K | EDGAR |
| 2026-04-03 | ARQT | Sell (S) | −10,000 | -$238.8K | EDGAR |
| 2026-04-01 | ARQT | Notice (144) | −10,000 | -$238.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.